You are here: Home / Our research / Pain Pharmacology Laboratory 

Professor Mark Connor

Honorary Professor
Brain & Mind Research Institute, School of Medical Sciences
Kolling Institute of Medical Research

M02 - Mallet Street Campus
The University of Sydney
NSW 2006 Australia

T:9850 4042
E:

Research interests

pharmacology, analgesia, cellular mechanisms in pain, opioids, vanilloid receptors

Back to Top

Current national competitive grants*

2010

Mechanisms of serotonergic and triptan mediated analgesia within the midbrain
Vaughan C, Connor M, Jeong H
NHMRC Project Grant ($527,500 over 3 years)

2008

Anandamide activated chloride channels in sensory neurons
Connor M, Christie M
ARC Discovery Projects ($255,000 over 3 years)

Effects of muscle inflammation on sensory neuron excitability
Connor M, Vaughan C
NHMRC Project Grant ($408,500 over 3 years)

* Grants administered through the University of Sydney

Back to Top

Publications

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003

2009

  
  • Connor, M. Shadows across mu-Star? Constitutively active mu-opioid receptors revisited. British Journal of Pharmacology. 2009; 156:1041-1043. [Abstract]
  • Ross, H., Gilmore, A., Connor, M. Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine. British Journal of Pharmacology. 2009; 156:740-750. [Abstract]
  • Connor, M. Allopurinol for pain relief: more than just crystal clearance?. British journal of pharmacology. 2009; 156:4-6. [Abstract]

2008

  
Back to Top
  • Ross, H., Napier, I., Connor, M. Inhibition of recombinant human T-type calcium channels bY u9-tetrahydrocannabinol and cannabidiol. The Journal of biological chemistry. 2008; 283:16124-34. [Abstract]
  • Roberts, L., Ross, H., Connor, M. Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro. Neuropharmacology. 2008; 54:172-80. [Abstract]
  • Jeong, H., Chenu, D., Johnson, E., Connor, M., Vaughan, C. Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Molecular pain. 2008; 4:54-65. [Abstract]

2007

  
Back to Top
  • Johnson, E., Connor, M. Towards a Receptor for Nocistatin?. British journal of pharmacology. 2007; 152:415-6. [Abstract]
  • Edwards, M., Loxley, R., Williams, A., Connor, M., Phillips, J. Lack of functional expression of NMDA receptors in PC12 cells. Neurotoxicology. 2007; 28:876-85. [Abstract]

2006

  
Back to Top
  • Johnson, E., Chieng, B., Napier, I., Connor, M. Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice. British journal of pharmacology. 2006; 148:947-55. [Abstract]
  • Connor, M., Kitchen, I. Has the sun set on kappa3-opioid receptors?. British journal of pharmacology. 2006; 147:349-50. [Abstract]
  • Roberts, L., Connor, M. TRPV1 antagonists as a potential treatment for hyperalgesia. Recent patents on CNS drug discovery. 2006; 1:65-76. [Abstract]

2005

  
Back to Top
  • Bagley, E., Chieng, B., Christie, M., Connor, M. Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine. British journal of pharmacology. 2005; 146:68-76. [Abstract]
  • Connor, M., Vaughan, C. Humanizing mice: catching up with elusive B1 receptors. British journal of pharmacology. 2005; 144:885-6. [Abstract]
  • Bailey, C., Connor, M. Opioids: cellular mechanisms of tolerance and physical dependence. Current opinion in pharmacology. 2005; 5:60-8. [Abstract]
  • Connor, M., Naves, L., McCleskey, E. Contrasting phenotypes of putative proprioceptive and nociceptive trigeminal neurons innervating jaw muscle in rat. Molecular pain. 2005; 1:31. [Abstract]
  • Johnson, E., Christie, M., Connor, M. The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment. Neuro-Signals. 2005; 14:290-302. [Abstract]

2004

  
Back to Top
  • Connor, M., Osborne, P., Christie, M. Mu-opioid receptor desensitization: is morphine different?. British journal of pharmacology. 2004; 143:685-96. [Abstract]
  • Connor, M., Bagley, E., Mitchell, V., Ingram, S., Christie, M., Humphrey, P., Vaughan, C. Cellular actions of somatostatin on rat periaqueductal grey neurons in vitro. British journal of pharmacology. 2004; 142:1273-80. [Abstract]

2003

  
Back to Top
  • Chebib, M., Duke, R., Duke, C., Connor, M., Mewett, K., Johnston, G. Convulsant actions of calycanthine. Toxicology and applied pharmacology. 2003; 190:58-64. [Abstract]
  • Borgland, S., Connor, M., Osborne, P., Furness, J., Christie, M. Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors. The Journal of biological chemistry. 2003; 278:18776-84. [Abstract]